Hemodialysis Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 37.31 Billion |
| Market Size (2029) | USD 48.08 Billion |
| CAGR (2024 - 2029) | 5.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Hemodialysis Market Analysis
The Global Hemodialysis Market size is estimated at USD 37.31 billion in 2024, and is expected to reach USD 48.08 billion by 2029, growing at a CAGR of 5.20% during the forecast period (2024-2029).
The COVID-19 pandemic had a substantial influence on the healthcare systems, with serious ramifications for both COVID-19-infected patients and non-patients, leading to the cancellation of diagnostic and treatments. The government's restrictions to prevent the spread of the coronavirus among people have lowered the demand for treatment services for chronic diseases such as kidney disease, diabetes, and hypertension, leading to the closure of healthcare clinics, and hospitals. This restricted the diagnosis and treatment of patients with chronic kidney diseases and hampered market expansion. For instance, according to an article published by Elsevier in Kidney International Reports, in September 2020, titled 'The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India', the availability of consumables for hemodialysis and peritoneal dialysis and essential medicines were affected by the lockdown across the globe. The total number of patients on regular dialysis decreased from 2517 to 2404 (from 972 to 928 in public and from 1545 to 1476 in the private sector). In addition, as per the same source,28.2% of patients missed 1 or more sessions of dialysis during the initial 3 weeks of lockdown and the treating nephrologists advised an additional 77 patients (47 in the public and 30 in the public sectors) to reduce their frequency of dialysis to accommodate potential dialysis requirements for COVID-19-positive patients and limitations imposed by the hospitals. Thus, the lack of availability of dialysis services in the public and private hospitals has severely impacted the patients, thus impacting the market growth.
However, the people affected by the COVID-19 pandemic were found to develop kidney diseases and other chronic conditions. For instance, according to an article published by Johns Hopkins University, in March 2022, titled 'COVID-19 Impact on Patients with Kidney Disease', it has been observed that the people infected with COVID-19 showed signs of kidney damage, and even those with no prior kidney problems were infected with the kidney disease. The rising risk of developing chronic kidney diseases and acute kidney injury among patients is likely to increase the demand for hemodialysis, thereby boosting the market growth.
Certain factors that are propelling the market growth are the rising number of end-stage renal diseases and increasing incidences of diabetes and hypertension among the population. For instance, according to the 2020 report of the International Society of Nephrology (ISN), kidney disease affects approximately 850 million population globally in 2020 and as per estimates, one in ten adults has chronic kidney disease (CKD). Further, as per the same source, the global burden of CKD is continuously increasing and is projected to become the 5th most common cause of years of life lost globally by 2040. Thus, the increasing burden of kidney diseases is expected to rise the market growth.
The increasing prevalence of hypertension and diabetes among the population is increasing the risk of developing kidney disease and kidney failure. Diabetic nephropathy is a common complication of type 1 and types 2 diabetes, as the blood vessel clusters in the kidney may get damaged, by the high blood glucose level in the patient, which helps in filtering the waste from the body and results in the renal damage. For instance, according to the 2022 statistics published by the International Diabetes Federation in the 10thedition of 2021, in Spain, 5,141.3 thousand people are living with diabetes, in 2021. In addition, as per the same source, this number is projected to reach 5,576 thousand by 2030 and 5,647.6 thousand by 2050. Also, as per the same source, 6,199.9 thousand people are living with diabetes, in 2021, in Germany. In addition, as per the same source, this number is projected to reach 6,519.7 thousand by 2030.
Furthermore, according to an article published by Clinical hypertension journal, in February 2021, titled 'Prevalence, awareness, treatment, and control of hypertension in Nigeria in 1995 and 2020: A systematic analysis of current evidence', it has been observed that 27.5 million people in Nigeria was having hypertension in 2020. In addition, as per the same source, about 29.0% of cases were aware that they had hypertension, 12.0% were receiving treatment, and 2.8% had blood pressure that was within the target range, in 2020, in Nigeria. Thus, the increasing burden of diabetes and hypertension among the population is expected to increase the risks of developing kidney diseases by narrowing the arteries and decreasing the blood flow to the kidneys, which is expected to increase the demand for hemodialysis treatment, thereby boosting the market growth.
However, the risks and complications associated with dialysis are expected to restrain the market growth.
Hemodialysis Market Trends
This section covers the major market trends shaping the Hemodialysis Market according to our research experts:
Conventional Long-term Hemodialysis is the Segment by Modality is Expected to Hold Largest Market Share over the Forecast Period
The Conventional Long-term Hemodialysis segment is expected to witness significant growth in the hemodialysis market over the forecast period owing to the factors such as the rising number of patients with chronic kidney diseases, increasing company activities, and huge acceptance of hemodialysis therapy over peritoneal dialysis among chronic kidney diseases (CKD) and end-stage renal disease (ESRD) patients.
The COVID-19 pandemic has affected hemodialysis procedures. However, to cope with the crisis created by COVID 19, in July 2021, NephroPlus launched its Dialysis on Call service in Hyderabad in a bed to expand its portfolio of service offerings by taking the dialysis setup to a patient's place and conducting the procedure at their convenience. The advantage of the service is that the machine and other equipment do not need to be stationed in the patient's home. Also, in July 2020, NephroPlus launched India's first 'Dialysis on Wheels' Program where a patient can undergo dialysis inside an ambulance itself that comes to their home and is accessible to patients across Delhi, Gurgaon, Faridabad, Ghaziabad, and Noida region. This model is anticipated to drastically reduce the cost of home hemodialysis, which will encourage more patient adoption. Additionally, the relaxation in lockdown guidelines is increasing the therapeutic procedural rate, which further increases the segment growth.
In addition, according to the Organ Procurement and Transplantation Network, around 92,000 people as of February 2022 are waiting for kidney transplants in the United States. In addition, as per the same source, in 2021, 25,490 people (or about 1 in 5) were able to get a kidney transplant in the United States. Thus, owing to the shortage of kidneys for transplant is expected to increase the demand for hemodialysis among the population which further increases the market growth over the forecast period.
Furthermore, major manufacturers have focused on developing specialized dialysis equipment coupled with growing partnerships and collaboration among market players, which is expected to drive the market's growth. Currently, various home and in-center hemodialysis machines are available in the market. For instance, in June 2021, Max Healthcare's Max@Home service launched home hemodialysis services for patients in collaboration with NephroPlus. Also, in October 2020, Fresenius Medical Care North America (FMCNA) entered into an innovative partnership with Livongo Health, Inc, to improve the lives and outcomes of people with late-stage chronic kidney disease (CKD) by increasing optimal dialysis starts, as well as offer earlier evaluation of transplantation and home dialysis options.
Therefore, owing to the aforementioned factors, the studied market is expected to have significant growth over the forecast period.
North America is Expected to Hold Largest Market Share over the Forecast Period
North America is expected to dominate the hemodialysis market over the forecast period owing to the factors such as the increasing prevalence of chronic kidney diseases, hypertension, and diabetes, well-established healthcare infrastructure, and high healthcare spending in the region.
The rising burden of chronic diseases such as kidney diseases, diabetes, and hypertension is the key factor driving the market growth over the forecast period. For instance, according to 2022 statistics published by the International Diabetes Federation, in the 10thedition of 2021, 2,974.0 thousand people were living with diabetes 2021 in Canada. In addition, as per the same source, this number is projected to reach 3,288.2 thousand by 2030 and 3,468.5 thousand by 2045. As per the same source, 32,215.3 thousand people were living with diabetes in 2021 in the United States and this number is projected to reach 34,755.3 thousand by 2030 and 36,289.9 thousand by 2045. Thus, the increasing number of diabetes cases is expected to increase the risk of developing kidney diseases in patients which are expected to increase the demand for hemodialysis procedures, thereby boosting the market growth. Similarly, according to the data published by the Centers for Disease Control and Prevention in Chronic Kidney Disease in the United States 2021 report, it has been observed that the people aged 65 years and above have the highest prevalence of chronic kidney disease with 38%, followed by people ages 45 to 64 (12%) and people ages 18 to 44 (6%), in the United States.
Furthermore, the rising geriatric population in the region who are more prone to develop hypertension, diabetes and chronic kidney diseases are also contributing to the market growth over the forecast period. For instance, according to the 2022 statistics published by the United Nations Population Fund, in the United States, a large proportion of the living population is aged 15-64 and accounts for 65% in 2022. In addition, as per the same source, 17% of the population is aged 65 years and above in 2022. Thus, the increasing aging population is expected to develop chronic kidney disaeses an end-stage renal diseases which increases the demand for dialysis and kidney transplantation, thereby boosting the market.
Moreover, the rising company activities in developing advacnced hemodialysis machine, and consumables are also contributing to the market growth. For instance, in December 2020, Medtronic launched its Carpediem Cardio-Renal Paediatric Dialysis Emergency Machine in the United States upon receiving Food and Drug Administration's (FDA) marketing authorization. The first machine was installed at Cincinnati Children's Hospital Medical Center. Also, in October 2020, Diality invested around USD 12.5 million in developing a portable hemodialysis system to address the unmet technology needs of the evolving dialysis industry.
Therefore, owing to the aforementioned factors, the studied market is expected to have a significant growth in the region over the forecast period.
Hemodialysis Industry Overview
The market studied is a moderately consolidated market owing to the presence of market players. Some of the players in the hemodialysis market are Asahi Kasei Corporation, B Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cantel Medical Corp., and DaVita Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic PLC, and Nipro Corporation.
Hemodialysis Market Leaders
-
Asahi Kasei Corporation
-
B Braun Melsungen AG
-
Fresenius Medical Care AG & Co. KGaA
-
Baxter International Inc.
-
Becton, Dickinson and Company
*Disclaimer: Major Players sorted in no particular order
Hemodialysis Market News
- In March 2022, Nipro Medical Corporation launched SURDIAL DX Hemodialysis System in the United States. The system is designed to create an optimal dialysis treatment experience for patients and clinicians.
- In January 2022, NextKidney acquired Dialysis to boost the development of its portable Neokidney hemodialysis device.
Hemodialysis Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Number of End Stage Renal Disease Patients
4.2.2 Increasing Incidence of Diabetes and Hypertension
4.3 Market Restraints
4.3.1 Risks and Complications Associated with Dialysis
4.4 Industry Attractiveness - Porter's Five Forces Analysis
4.4.1 Bargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value in USD million)
5.1 By Product Type
5.1.1 Equipment
5.1.1.1 Dialysis Machines
5.1.1.2 Hemodialysis Water Treatment Systems
5.1.1.3 Other Hemodialysis Equipment
5.1.2 Consumables
5.1.2.1 Dialyzers
5.1.2.2 Catheters
5.1.2.3 Other Hemodialysis Consumables
5.2 By Modality
5.2.1 Conventional Long-term Hemodialysis
5.2.2 Short Daily Hemodialysis
5.2.3 Nocturnal hemodialysis
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Asahi Kasei Corporation
6.1.2 B Braun Melsungen AG
6.1.3 Baxter International Inc.
6.1.4 Becton, Dickinson and Company
6.1.5 Hu-Friedy Mfg. Co., LLC (Cantel Medical Corp.)
6.1.6 DaVita Inc.
6.1.7 Fresenius Medical Care AG & Co. KGaA
6.1.8 Medtronic PLC
6.1.9 Nipro Corporation
6.1.10 Rockwell Medical Inc.
6.1.11 Toray Medical Co. Ltd
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Hemodialysis Industry Segmentation
As per the scope of this report, Hemodialysis is a process where the blood is cleaned using a dialysis machine by using a specific filter called an artificial kidney, or a dialyzer. Hemodialysis helps regulate vital blood minerals like potassium, salt, and calcium as well as blood pressure. The Hemodialysis Market is Segmented by Product Type (Equipment and Consumables), Modality (Conventional Long-term Hemodialysis, Short Daily Hemodialysis, and Nocturnal Hemodialysis), and Geography (North America, Europe, Asia Pacific, Middle-East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product Type | |||||
| |||||
|
| By Modality | |
| Conventional Long-term Hemodialysis | |
| Short Daily Hemodialysis | |
| Nocturnal hemodialysis |
| By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Hemodialysis Market Research FAQs
How big is the Global Hemodialysis Market?
The Global Hemodialysis Market size is expected to reach USD 37.31 billion in 2024 and grow at a CAGR of 5.20% to reach USD 48.08 billion by 2029.
What is the current Global Hemodialysis Market size?
In 2024, the Global Hemodialysis Market size is expected to reach USD 37.31 billion.
Who are the key players in Global Hemodialysis Market?
Asahi Kasei Corporation, B Braun Melsungen AG, Fresenius Medical Care AG & Co. KGaA, Baxter International Inc. and Becton, Dickinson and Company are the major companies operating in the Global Hemodialysis Market.
Which is the fastest growing region in Global Hemodialysis Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Hemodialysis Market?
In 2024, the North America accounts for the largest market share in Global Hemodialysis Market.
What years does this Global Hemodialysis Market cover, and what was the market size in 2023?
In 2023, the Global Hemodialysis Market size was estimated at USD 35.47 billion. The report covers the Global Hemodialysis Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Hemodialysis Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Hemodialysis Industry Report
Statistics for the 2024 Hemodialysis market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Hemodialysis analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
